TY - JOUR T1 - Early Cost-Utility Analysis of Ataluren and Eteplirsen in the Treatment of Duchenne Muscular Dystrophy in Egypt JO - Value in Health Regional Issues UR - http://dx.doi.org/10.1016/j.vhri.2023.08.004 PY - 2023/10/18 AU - Shehata Z AU - Metry A AU - Rabea H AU - El Sherif R AU - Abdelrahim M AU - Dawoud D ED - DO - DOI: 10.1016/j.vhri.2023.08.004 PB - Elsevier BV VL - 38 SP - 109 EP - 117 Y2 - 2025/06/23 ER -